Subscribe To
Ionis pharmaceuticals (ions) q4 earnings and revenues beat estimates
Ionis pharmaceuticals (IONS) delivered earnings and revenue surprises of 76.25% and 30.36%, respectivel...
February 24, 2022, 10:50 am
Oncotelic presenting at medinvest pharmaceutical and biotechnology investor conference
AGOURA HILLS, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. ( “ Oncotelic ” or the “ Company ” ) ( OTCQB:OTLC ) , a l...
February 24, 2022, 8:47 am
Oncotelic presenting at medinvest pharmaceutical and biotechnology investor conference
AGOURA HILLS, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. ( “ Oncotelic ” or the “ Company ” ) ( OTCQB:OTLC ) , a l...
February 24, 2022, 8:47 am
Oncotelic presenting at medinvest pharmaceutical and biotechnology investor conference
AGOURA HILLS, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. ( “ Oncotelic ” or the “ Company ” ) ( OTCQB:OTLC ) , a l...
February 24, 2022, 8:47 am
Hikma pharmaceuticals sales grow 9%, announces us$300mln share buyback
Hikma pharmaceuticals PLC (AIM:HIK, OTC:HKMPF) reported “solid growth” for 2021, with sales rising ...
February 24, 2022, 5:51 am
Hikma pharmaceuticals sales grow 9%, announces us$300mln share buyback
Hikma pharmaceuticals PLC (AIM:HIK, OTC:HKMPF) reported “solid growth” for 2021, with sales rising ...
February 24, 2022, 5:51 am
Hikma pharmaceuticals sales grow 9%, announces us$300mln share buyback
Hikma pharmaceuticals PLC (AIM:HIK, OTC:HKMPF) reported “solid growth” for 2021, with sales rising ...
February 24, 2022, 5:51 am
Vanda pharmaceuticals inc. (vnda) ceo mihael polymeropoulos on q4 2021 results - earnings call transcript
Vanda pharmaceuticals Inc. (VNDA) CEO Mihael Polymeropoulos on Q4 2021 Results - Earnings Call Transcri...
February 23, 2022, 10:18 pm
Vanda pharmaceuticals inc. (vnda) ceo mihael polymeropoulos on q4 2021 results - earnings call transcript
Vanda pharmaceuticals Inc. (VNDA) CEO Mihael Polymeropoulos on Q4 2021 Results - Earnings Call Transcri...
February 23, 2022, 10:18 pm
Vanda pharmaceuticals inc. (vnda) ceo mihael polymeropoulos on q4 2021 results - earnings call transcript
Vanda pharmaceuticals Inc. (VNDA) CEO Mihael Polymeropoulos on Q4 2021 Results - Earnings Call Transcri...
February 23, 2022, 10:18 pm
Biomarin pharmaceutical inc. (bmrn) ceo j.j. bienaime on q4 2021 results - earnings call transcript
BioMarin pharmaceutical Inc. (BMRN) CEO J.J. Bienaime on Q4 2021 Results - Earnings Call Transcript...
February 23, 2022, 9:18 pm
Biomarin pharmaceutical inc. (bmrn) ceo j.j. bienaime on q4 2021 results - earnings call transcript
BioMarin pharmaceutical Inc. (BMRN) CEO J.J. Bienaime on Q4 2021 Results - Earnings Call Transcript...
February 23, 2022, 9:18 pm
Biomarin pharmaceutical inc. (bmrn) ceo j.j. bienaime on q4 2021 results - earnings call transcript
BioMarin pharmaceutical Inc. (BMRN) CEO J.J. Bienaime on Q4 2021 Results - Earnings Call Transcript...
February 23, 2022, 9:18 pm
Biomarin pharmaceutical (bmrn) q4 earnings and revenues top estimates
BioMarin (BMRN) delivered earnings and revenue surprises of 250% and 1.22%, respectively, for the quarter ended December 2021. Do the numbers hold clu...
February 23, 2022, 7:12 pm
Biomarin pharmaceutical (bmrn) q4 earnings and revenues top estimates
BioMarin (BMRN) delivered earnings and revenue surprises of 250% and 1.22%, respectively, for the quarter ended December 2021. Do the numbers hold clu...
February 23, 2022, 7:12 pm
Biomarin pharmaceutical (bmrn) q4 earnings and revenues top estimates
BioMarin (BMRN) delivered earnings and revenue surprises of 250% and 1.22%, respectively, for the quarter ended December 2021. Do the numbers hold clu...
February 23, 2022, 7:12 pm
Why biocryst pharmaceuticals stock slid today
The biotech's immediate future doesn't look profitable....
February 23, 2022, 6:30 pm
Why biocryst pharmaceuticals stock slid today
The biotech's immediate future doesn't look profitable....
February 23, 2022, 6:30 pm
Why biocryst pharmaceuticals stock slid today
The biotech's immediate future doesn't look profitable....
February 23, 2022, 6:30 pm
Moderna's story is what's the encore to covid-19, says bank of america's geoff meacham
Geoff Meacham, Bank of America senior pharmaceutical analyst, joins 'Power Lunch' to preview Moderna's ...
February 23, 2022, 5:09 pm